Hypothalamic mechanisms of pain modulatory actions of cytokines and prostaglandin E2

Annals of the New York Academy of Sciences

Volumn 917, Issue , 2000, Pages 106-120

  Hori, T ^a   Oka, T ^a   Hosoi, M ^a   Abe, M ^a   Oka, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; BLOOD BRAIN BARRIER; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTROPHYSIOLOGY; ENDOTHELIUM CELL; HORMONE ACTION; HYPERALGESIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NONHUMAN; PAIN; PAIN THRESHOLD; RECEPTOR BLOCKING; SENSITIZATION; TAIL FLICK TEST;

ANIMALIA;

EID: 0033669570     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05375.x     Document Type: Conference Paper

References (74)

1. The phenomenon of the acute phase response
2. Immune cytokines and regulation of body temperature, food intake and cellular immunity
3. Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue
4. First and second phases of biphasic fever: Two sequential stages of the sickness syndrome?
5. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin
6. Neurocircuitry of illness-induced hyperalgesia
7. Acute and conditioned hyperalgesic responses to illness
8. The preoptic hypothalamus mediates hyperalgesia induced by intravenous injection of lipopolysaccharide
9. Inhibition of peripheral interleukin-1β-induced hyperalgesia by the intracerebroventricular administration of diclofenac and a-melanocyte-stimulating hormone
10. Cytokines in the brain
11. The role of cytokines in neurodegeneration
12. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: A pathway for the induction of non-specific symptoms of sickness?
13. Interleukin-6 and tumor necrosis factor in cerebrospinal fluid: Changes during pyrogen fever
14. Regional induction of tumor necrosis factor α expression in the mouse brain after systemic lipopolysaccharide administration
15. Rapid induction of tumor necrosis factor α in the cerebrospinal fluid after intracerebroventricular injection of lipopolysaccharide revealed by a sensitive capture immuno-PCR assay
16. Interleukin (IL)-1β, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications
17. Intracerebroventricular injection of interleukin-1β induces hyperalgesia in rats
18. Intracerebroventricular injection of interleukin-1β enhances nociceptive neuronal responses of the trigeminal nuicleus caudalis in rats
19. Characterization of cytokine-induced hyperalgesia
20. Intracerebroventricular injection of interleukin-6 induces thermal hyperalgesia in rats
21. Intracerebroventricular injection of tumor necrosis factor-α induces thermal hyperalgesia in rats
22. α-MSH modulates Fos expression in the paraventricular nucleus and hyperalgesia induced by intracerebroventricular administration of interleukin-1β in rats
23. Interleukin-1 induces analgesia in mice by a central action
24. Central effects of tumor necrosis factor-α and interleukin-1α on nociceptive thresholds and spontaneous locomotor activity
25. Involvement of corticotropin-releasing factor in the antinociception produced by interleukin-1 in mice
26. CRH and the noradrenergic system mediate the antinociceptive effect of central interleukin-1α in the rat
27. Pyrogenic doses of intracerebroventricular interleukin-1 did not induce analgesia in the rat hot-plate or cold-water tail flick tests
28. Biphasic effects of intracerebroventricular interleukin-1β on mechanical nociception in the rat
29. The opposing effects of interleukin-1β micro-injected into the preoptic hypothalamus and the ventromedial hypothalamus on nociceptive behavior in rats
30. Hypothalamic and thalamic sites of action of interleukin-1β on food intake, body temperature and pain sensitivity in the rat
31. 2 induces thermal hyperalgesia in rats: The possible involvement of EP3 receptors
32. Prostaglandin formation in the hypothalamus in vivo: Effect of pyrogens
33. 2 levels in several brain areas as determined by microdialysis
34. 2 during lipopolysaccharide-induced fever in guinea pigs
35. 2 from rat hypothalamic explants in vitro
36. 2(α) in the rat, I. behavioral, antinociceptive and anticonvulsant actions of intraventricular prostaglandins in the rat
37. 2 on pain and inflammation
38. 2 in the rat
39. 2 binding sites in monkey diencephalon
40. 2 binding sites in rat brain using quantitative autoradiography
41. Distribution of the messenger RNA for the prostaglandin E receptor subtype EP3 in the mouse nervous system
42. 2 sensitivity of the organum vasculosum lamina terminalis region and preoptic area in rat brain slices
43. 2 in rats
44. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype
45. Cloning and expression of cDNA for the human prostaglandin E receptor EP1 subtype
46. 2 prostanoid receptor subtypes
47. 2 may be mediated through different EP receptor subtypes in rats
48. Prostaglandin E receptor EP3 subtype is involved in thermal hyperalgesia through its actions in the preoptic hypothalamus and the diagonal band of Broca in rats
49. 2 has antinociceptive effect through EP1 receptor in the ventromedial hypothalamus in rats
50. Molecular characterization of the mouse prostanoid EP1 receptor gene
51. Molecular biology of prostanoid receptors; an overview
52. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype
53. Down-regulation of prostaglandin E receptors and homologous desensitization of isolated adipocytes
54. 2 receptors in rat renal medulla
55. Two isoforms of prostaglandin E receptor EP3 subtype
56. 2-induced hyperthermia in rats
57. 2 increases splenic sympathetic nerve activity in rats
58. 2 may induce hyperthrmia through EP1 receptor in the anterior wall of the third ventricle and neighboring preoptic regions
59. Prostaglandin E2: A putative fever mediator
60. Mechanisms of CNS response to systemic immune challenge: The febrile response
61. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygefiase enzymes (COX-1 and COX-2) in the rat brain
62. Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: Light and electron microscopic immunocytochemical studies
63. Descending control of nociception
64. Reciprocal connections between the medial preoptic area and the midbrain periaqueductal gray in rat: A WGA-HRP and PHA-L study
65. Analgesia from rostral brain stem stimulation in the rat
66. Inhibition of spinal dorsal horn neuronal responses to noxious skin heating by medial preoptic and septal stimulation in the cat
67. Medial hypothalamic stimulation suppresses nociceptive spinal dorsal horn neurons but not the tail-flick reflex in the rat
68. Suppression of the hinlimb flexor reflex by stimulation of the medial hypothalamus and thalamus in the rat
69. Hypothalamic control of nocireceptive and other neurones in the marginal layer of the dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat
70. Descending pain inhibitory system involved in acupuncture analgesia
71. Effects of interleukin-1 and arachidonate on the preoptic and anterior hypothalamic neurons
72. Recombinant human intefieukin-1β alters the activity of preoptic thermosensitive neurons in vitro
73. Blockade by interleukin-1 receptor antagonist of IL-1β-induced neuronal activity in guinea pig preoptic area slices
74. Actions of interferon-α and interleukin-1β on glucose-responsive neurons in the ventromedial hypothalamus